1. Andreasen, J.T., Bach, A., Gynther, M., Nasser, A., Mogensen, J., Strømgaard, K. & Pickering, D.S. (2013) UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801. Neuropharmacology, 67, 193-200.
2. Begon, S., Pickering, G., Eschalier, A. & Dubray, C. (2000) Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res., 887, 436-439.
3. Berrino, L., Oliva, P., Massimo, F., Aurilio, C., Maione, S., Grella, A. & Rossi, F. (2003) Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur. J. Pain, 7, 131-137.
4. Boettger, M.K., Uceyler, N., Zelenka, M., Schmitt, A., Reif, A., Chen, Y. & Sommer, C. (2007) Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur. J. Pain, 11, 810-818.
5. Boyce, S., Wyatt, A., Webb, J.K., O’Donnell, R., Mason, G., Rigby, M., Sirinathsinghji, D., Hill, R.G. & Rupniak, N.M. (1999) Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology, 38, 611-623.